Introduction
Cystic cerebral metastases from a papillary carcinoma of thyroid are rare.This paper discusses one such case where the patient's treatment of his primary thyroid condition was somewhat incomplete and which later resulted in the formation of a large cystic right parieto-occipital lesion. Excision of accessible cerebral metastases was possible followed by routine radiotherapy. The clinical outcome was favorable.
II.
Case Report 3 .1The patient, a 52 year old male, presented with a swelling in the right parieto-occipital region that grew gradually over the past 1 year. It was painless but the swelling increased in size rapidly over the last 1 month. Moreover, since the last 1 month, the patient complained of a rapidly progressing weakness of the left upper and lower limbs. This was complimented by headache accompanied by projectile vomiting during early mornings over the same period and sporadic transient visual loss s/o increased intracranial pressure.
3.2Past history:
The patient already had a history of papillary carcinoma of the thyroid. Thyroidectomy was performed 3 years ago but surgical details were unavailable. No radio-iodine treatment or relevant radiotherapy was given in the post-operative period. The patient did not go for regular follow up with his attending surgeon and came to us with this large swelling in his scalp.
3.3Examination findings:
A large scalp swelling, measuring 20 cms x 15 cms in the right parieto-occipital region was noticed. Overlying skin was stretched and shiny. There was no evidence of ulcerations and skin was mobile and there were no signs of inflammation. The swelling had a cystic consistency, was non-compressible, non-pulsatile with no cough impulse. (Fig 1) It was also negative for trans-illumination. Few enlarged lymphnodes were palpable in the cervical region and right axilla. A post-operative scar on the thyroid region was observed.
Fig 1:
A large scalp swelling, measuring 20 cms x 15 cms in the right parieto-occipital region was noticed. Overlying skin was stretched and shiny. There was no evidence of ulcerations and skin was mobile and there were no signs of inflammation He was fully conscious and coherent. However, left hemiparesis of MRC (Medical Research council) grade 3/5 was present. Examination of fundus revealed papilloedema suggestive of increased intracranial pressure and there was no evidence of spinal tenderness or stiffness in neck. Higher mental functions and other cranial nerves were normal.
3.4Investigations:
Routine investigations including erythrocyte sedimentation rate and C-reactive protein were normal. The underlying bone was eroded due to invasion by the tumor. The intracranial component in the right parieto-occipital region was predominantly cystic with a small hyperdense solid component in the anterior portion. The wall of the intracranial part was also hyperdense with focal areas of further higher density, probably calcifications. There was moderate amount of oedema surrounding the lesion. A second small hyperdense lesion was seen in the left frontal lobe.
MRI (Magnetic Resonanace Imaging) Brain Plain:
Both the intra and extracranial portions were predominantly cystic. The cystic components are hyperintense on T1 weighted and T2 weighted images suggestive of subacute bleed. The cysts were septated. The walls of the lesion and small solid areas are 1.5Treatment: Treatment was based on antiepileptic drugs. Injection dexamethasone 8mg stat was given, followed by 4mg thrice a day. Surgery was performed and gross total excision of the right parietooccipital lesion was achieved. The overlying skin was free of the tumor. The tumor was well defined from brain parenchyma and soft with predominantly cystic areas filled with hemorraghic fluid. The small solid components were greyish, moderately vascular and suckable. The wall was thick and well defined. The tumor was eroding the parieto-occipital bone and breaching the dura mater to invade the brain parenchyma. After complete excision,lax watertight duroplasty was performed with pericranial fascia and calvarium was repaired with titanium mesh.
1.6Post-operative Course:
Post-operative period was uneventful and the patient was referred to a radiotherapist for further management.
III. Discusssion
Although brain metastases from papillary thyroid carcinoma is rare, Dinneen noted that approximately 18% of patients with distant metastases resulting from papillary thyroid carcinoma developed brain metastases and that the brain was a common second location for distant spread. 
Incidence of papillary carcinoma of thyroid and brain metastases:
It is clearly observed that metastatic spread of thyroid carcinoma to the brain is rare. Brain metastases of the cystic nature, occurring from differentiated thyroid carcinoma is extremely rare. Moreover, McConahey of the Mayo Clinic has shown that the presence of extracranial distant metastases is also a risk factor for the development of brain metastases. His studies have shown that nearly 15% of the patients with metastatic papillary carcinoma developed brain metastasis at some point of time. 4.2Risk factors for brain metastases : Early detection of brain metastasis is crucial because the intracranial metastatic lesion can be life threatening. Statistics show that the reported survival time is usually less than 1 year after brain metastases following thyroid cancer is diagnosed. 3, 4 Appropriate treatment must start immediately to enhance long-term survival because papillary carcinoma of thyroid has a relatively less severe clinical course unless associated with distant metastases. Moreover, given the frequent association of brain metastases coexistent with other sites of distant metastases, it would seem reasonable to consider routine MRI examination of the brain in an old patient with thyroid carcinoma who develops any evidence of distant metastatic disease. The presence of brain metastasis is a negative prognostic factor; therefore, treatment must be tailored to the individual patient. Surgery, radiotherapy, and radioiodine treatment have been used with varying results for treatment of brain metastases from thyroid carcinoma. A solitary lesion with complete surgical resection usually results in a better prognosis. 3 
5.3Presenting symptoms:
Brain metastasis present with focal neurological deficits like weakness, , cognitive impairment and sensory loss or with symptoms of raised intracranial pressure like headache, vomitings. Therefore, any patient with a history of differentiated thyroid carcinoma with neurological symptoms such as these is a suspect for brain metastasis.
Treatment options:
Treatment for papillary carcinoma of thyroid and brain metastases is not clearly defined and varies on a case to case basis. Patients may be treated conservatively or by surgical resection, external radiation and radioactive iodine. Gamma knife surgery is also an extremely suitable alternative route of treatment, particularly in cases where patients are at a high risk for open surgery or where surgery becomes impossible. Gamma knife radiosurgery was effective in treating isolated lesions with survival rates of up to 61.3 months and worked well in those patients who risked high morbidity in case they underwent craniotomy. 5 Radiosurgery in fact, is the most effective minimally invasive strategy for brain metastases management. Multiple lesions may be treated through whole brain irradiation and have yielded some very positive results.
Since thyroid carcinoma is of a slow-growing nature, resection is certainly a right choice of treatment where it is possible or the metastasis is symptomatic. In more aggressive tumors like anaplastic carcinoma for instance, Chiu also reported a significant increase in survival for those patients who underwent surgical resection. Survivals of 18.7 months, 25.5 months and 2.7 months, respectively, were reported in patients undergoing GTR, PR and those without surgery, respectively.
Macroscopic total resection of lesions that are surgically accessible is an excellent treatment method, especially in patients, with a single metastasis or those who are suffering significant mass effect caused by the lesions. If treatment with radioactive iodine is planned, caution should be taken to prevent rapid worsening of tumor growth during thyroid withdrawal, and to minimize any edema that may be the result of treatment. 7 Chemotherapy, it has been noted, only has a limited role in differentiated thyroid carcinoma management with both extracranial and intracranial metastases. 
Prognosis
Papillary carcinoma of thyroid is perhaps the most common form of thyroidal malignancy. However, its prognosis is excellent and distant metastases is also rare. However, should metastases occur in the bones or lungs, the prognosis may be unfavorable. Metastasis of brain from papillary thyroid carcinoma is indeed rare with a frequency of 0.1 to 5 %. 5 It has also been observed that the prognosis for patient subgroups that develop distant metastasis is unfavorable, particularly in the age groups of < 20 years and > 60 years with Grade 3 or 4 cancers and a thyroid lesion of more than 4 cm as also extra thyroid lesions when initially diagnosed. These groups are more prone to a higher chance of distant metastases and which seriously impacts survival. 8 
IV. Conclusions
Papillary carcinoma of thyroid rarely causes cerebral metastases; Improper or inadequate treatment of primary thyroid disease increases the risk of cerebral and distant metastases; and excision of accessible cerebral metastases has a favorable clinical outcome.
